MOLLI Surgical is pleased to announce that Tufts Medical Center, a prominent academic medical institution in Massachusetts, is now employing the MOLLI® 2 System for breast cancer surgeries.

This innovative technology is also being used at MelroseWakefield Hospital, another facility within Tufts Medicine.

The MOLLI® 2 System, renowned for its wire-free and radiation-free approach to lesion localization, has received positive feedback from surgeons for its accuracy and user-friendliness.

The hospital’s dedication to integrating new technologies that enhance patient care while maintaining operational efficiency.

“Tufts Medical Center is dedicated to adopting innovative solutions that improve patient outcomes without sacrificing precision or efficiency. The easy integration of the MOLLI 2 System has been beneficial for our surgical and radiological teams.”

The MOLLI 2 System features advanced directional 3D guidance that enables surgeons to pinpoint lesions with high precision. Radiologists mark lesions using the MOLLI® Marker, a device about the size of a sesame seed, while surgeons use the MOLLI® Wand and MOLLI® Tablet to locate these marks accurately.

The system is designed to be user-friendly, improving both surgical efficiency and patient satisfaction.

The company's commitment to enhancing patient care: “They designed the MOLLI 2 System to make precision surgery more effective and patient-centered.

They are excited to collaborate with Tufts Medical Center, as both organizations share a dedication to innovative and patient-focused breast cancer treatment.”

This collaboration underscores the commitment of Tufts Medical Center and MOLLI Surgical to advancing surgical precision, improving clinical workflows, and enhancing both patient and physician experiences.



 

 

 

Source: prnewswire.com

Report Abuse